Brief: Kintara Announces Grant From Luxembourg National Research Fund And Cancer Foundation Luxembourg
12/01/2022 14:18
Jan 12 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA ANNOUNCES GRANT FROM LUXEMBOURG NATIONAL RESEARCH
FUND
AND CANCER FOUNDATION LUXEMBOURG TO SUPPORT VAL-083'S MECHANISM
OF ACTION RESEARCH IN GLIOBLASTOMA
Source text for Eikon: ID:nPn3x0s1Ba
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.